MEDIPHARM LABS CORP's ticker is MEDIF and the CUSIP is 58504D100. A total of 1 filers reported holding MEDIPHARM LABS CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $355,000 | -26.8% | 670,008 | +21.5% | 0.08% | +260.9% |
| Q3 2020 | $485,000 | -9.9% | 551,454 | +17.9% | 0.02% | -90.0% |
| Q2 2020 | $538,000 | -22.0% | 467,734 | +7.9% | 0.23% | -61.8% |
| Q1 2020 | $690,000 | -41.6% | 433,674 | +9.2% | 0.60% | -18.5% |
| Q4 2019 | $1,182,000 | – | 397,028 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AdvisorShares Investments LLC | 467,734 | $538,000 | 0.23% |
| CAPTRUST FINANCIAL ADVISORS | 1,000 | $1,000 | 0.00% |